Beaumont Financial Advisors LLC Sells 407 Shares of iShares Biotechnology ETF $IBB

Beaumont Financial Advisors LLC lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,969 shares of the financial services provider’s stock after selling 407 shares during the period. Beaumont Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,135,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in IBB. Citigroup Inc. increased its holdings in iShares Biotechnology ETF by 88.5% during the first quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock valued at $410,322,000 after buying an additional 1,505,976 shares during the last quarter. Commonwealth Equity Services LLC increased its stake in iShares Biotechnology ETF by 12.0% in the 1st quarter. Commonwealth Equity Services LLC now owns 194,516 shares of the financial services provider’s stock worth $24,879,000 after buying an additional 20,915 shares during the period. Jones Financial Companies Lllp increased its position in iShares Biotechnology ETF by 763.3% during the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock valued at $19,347,000 after purchasing an additional 133,744 shares during the period. MAI Capital Management boosted its holdings in shares of iShares Biotechnology ETF by 4.2% in the 1st quarter. MAI Capital Management now owns 98,158 shares of the financial services provider’s stock valued at $12,554,000 after buying an additional 3,923 shares in the last quarter. Finally, Madrona Financial Services LLC boosted its stake in iShares Biotechnology ETF by 153.0% in the 1st quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock worth $10,379,000 after purchasing an additional 49,075 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.4%

NASDAQ:IBB opened at $140.96 on Friday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $150.04. The company has a 50 day moving average price of $137.83 and a 200-day moving average price of $129.56.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.